In conclusion, our evidence-based systematic review and meta-analysis demonstrates that podoplanin overexpression behaves as a biomarker of malignant transformation risk in the epithelium of oral potentially malignant disorders, singularly in oral leukoplakia. Here, PDPN is linked to Oral leukoplakia.